drugset / Trial / NCT01715051

D-Serine for Cocaine Dependence Pilot

NCT01715051

Phase 2 Withdrawn Theresa Winhusen
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of this study is to collect pilot data on the efficacy of D-serine, relative to placebo, as a cocaine dependence treatment. Secondary objectives include evaluating D-serine, relative to placebo, on: 1. safety in treating cocaine-dependent adults and 2. tolerability.

Timeline

Start
2014-02
Primary completion
2019-09
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator D-serine Unknown 60 mg/kg

Indications